Focused Wealth Management’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History
Bought
Maintained
Sold
Other funds holding TSRX
Focused Wealth Management's TSRX Position: Q4 2013 in Review
Focused Wealth Management sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q4 2013, closing a stake of 1,295 shares — an estimated $18K sold.
Focused Wealth Management first reported a position in TSRX in Q3 2013 and held it in 1 quarter. The position peaked at $18K in Q3 2013. 1 fund tracked by Wall St. Rank holds TSRX as of Q4 2013.
- Focused Wealth Management reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
- Focused Wealth Management sold 1,295 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q4 2013, an estimated $18K.
- Focused Wealth Management first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 1 quarter.
- Focused Wealth Management's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $18K in Q3 2013.
- 1 fund tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q4 2013.
Based on Focused Wealth Management's 13F filing for Q4 2013, filed 6 Feb 2014.